ASTRAZENECA PLCCompany logo

United Kingdom (GB)

OpenCorporation rating: 32.77 on 100

Ranking 2023: 372 on 602 companies


Primary and secondary NACE classification:
• Manufacture of pharmaceutical preparations (2120)
• Activities of holding companies (6420)

Company description

This company operates as an Anglo-Swedish multinational pharmaceutical and biopharmaceutical specialised in the discovery, development, manufacture, and commercialization of prescription medicines. It was founded in 1999 through the merger of the Swedish Astra AB and the English Zeneca Group. It has its headquarters in Cambridge, United Kingdom and research and development (R&D) headquarters in Sodertalje, Sweden and in Warsaw, Poland, and Gaithersburg, Maryland (location of MedImmune) for work on biopharmaceuticals.The company has a portfolio of products for major disease areas including oncology, cardiovascular and metabolic, respiratory, infection, gastrointestinal, and neuroscience diseases worldwide. It serves primary care and specialty care physicians through distributors and local representative offices. The company's pipeline includes 132 projects, of which 120 are in the clinical phase of development. It has collaboration agreements with Valeant Holdings Ireland, and Eli Lilly and Company; definitive agreement with Foundation Medicine, Inc.; strategic collaboration with FibroGen, Astellas, and Pieris Pharmaceuticals Inc; collaboration and license agreement with Celgene International Sarl; and license agreement with LEO Pharma A/S.

[…] show more

OpenCorporation questionnaire

The read only version of the questionnaire submitted to this company is publicly available: view questionnaire.

Indicators

The rating is calculated on the following metrics (for more information visit the section Methodology).

score (max is 100)
ratings 2022
52.9
52.9
14
14
43.7
43.7
63.8
63.8
0
0
48.8
37.8
0
33.9
33.9

YTD Rankings history

HQ and subsidiaries

ASTRAZENECA PLC
loading subsidiaries

* The position of map pins may not reflect the exact location

About this evaluation

This company did not compile the OpenCorporation questionnaire, for this reason this evaluation was made only on data available to the project staff.

Claims and support from the company

If as a company manager or official of ASTRAZENECA PLC you want to enter in touch with our staff, provide more information to OpenCorporation or get an account to access and compile the company questionnaire, please write an email to support@opencorporation.org.

Tell the OpenCorporation team

If you detect corporate behavior in contrast with what emerges from the OpenCorporation corporate rating card in your country, or in the branch where you work, report it to info@opencorporation.org so that our team can take it in account.

More evaluations

Permament links

The link below will always open the 2023 evaluation:

2023: https://www.opencorporation.org/en/ranking/astrazeneca-plc/2023    url copied

The link below will always open the latest evaluation available:

Last: https://www.opencorporation.org/en/ranking/astrazeneca-plc/last    url copied